Mitsubishi Chemical Holdings in Numbers

As of May. 2021

Group Companies / Business Domains

Organizational Structure

4Operationg Companies

The Mitsubishi Chemical Holdings Group currently consists of Mitsubishi Chemical Corporation, Mitsubishi Tanabe Pharma Corporation, Life Science Institute, Inc., and Nippon Sanso Holdings Corporation.

Business Domains

3Business Domains

The Mitsubishi Chemical Holdings Corporation Group provides diverse solutions through its three business domains: Performance Products, Industrial Materials and Health Care.

Number of employees (consolidated)

69,607

Group sites
(number of countries & regions)

43

Number of Subsidiaries

666

Value Creation Model—KAITEKI Management

Value Creation Model-KAITEKI Management

3Management Axes

We created our own management method called Value Creation Model—KAITEKI Management based on the following axes:

Management of Economies
Management of Technology
Management of Sustainability

MOE:Total assets

¥5,287.2
billion

MOT:Capital expenditures

¥263.7billion

MOT:R&D expenditures

¥126.1billion

MOS:Contribution to the reduction of
GHG emissions through products

62million t-CO2e

MOS:Amount of reused water supplied
(meeting quality standards for both daily and industrial use)

780million tons

Financial Data

FY2020 Sales Revenue
(IFRS)

¥3,257.5
billion

FY2020 Core Operating Income

¥174.7
billion

FY2020 ROE
(Return on equity)

-0.6%

FY2020 Ratio of overseas revenue

45.0%

Medium-Term Management Plan APTSIS 25 Step 1

Medium-Term Management Plan APTSIS 25 Step 1

FY2022
Core Operating
Income*

¥250.0billion

FY2022
ROE (IFRS)

10%

Core Operating Income: Gains/losses incurred by state gain/loss introduced in accordance with transition to IFRS.
Ordinary income excluding gains/losses incurred by non-recurring factors